Literature DB >> 2194200

Development of a sensitive activity assay for high-volume evaluation of human renin inhibitory peptides in rat serum: results with U-71,038.

M J Ruwart1, S K Sharma, D W Harris, D B Lakings, B D Rush, K F Wilkinson, J C Cornette, D B Evans, J M Friis, K J Cook.   

Abstract

A sensitive activity assay for high volume evaluation of human renin inhibitory peptides (RIPs) in rat sera (range 2-80 ng/ml) was developed based on the low affinity of RIPs to rat renin and their high affinity to human renin. The utility of this activity assay was tested by measuring concentrations of a human RIP, U-71,038 (BOC-Pro-Phe-N-MeHis-Leu psi [CHOHCH2]Val-Ile-Amp), in rat sera, determined by the activity assay, by a sensitive radioimmunoassay (RIA), and by tracking tritiated drug. Rats were given radiolabeled drug as an intravenous bolus, and blood samples were collected at various times after dosing. The serum level of U-71,038 equivalents was determined by the three techniques. Whole blood was also counted for total radioactivity to evaluate the potential for U-71,038 incorporation into red blood cells. Results from the three serum assays indicate good agreement between the calculated U-71,038 equivalents for the 30 min and 1 hr collection times. The 2 and 4 hr collection times show excellent agreement for the activity assay and RIA; [3H]-U-71,038 determinations gave substantially higher values. Serum levels for U-71,038 determined 30 min after dosing averaged less than 300 ng equivalents/ml suggesting that less than 1% of the administered dose was in the systemic circulation at that time. Thus, U-71,038 was rapidly cleared. At the 4 hr collection time, the level of U-71,038 equivalents, as determined by activity assay and RIA, was ten times the in vitro IC50 for the renin inhibitory activity of U-71,038.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194200     DOI: 10.1023/a:1015883709275

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

Review 1.  Renin-angiotensin system: biochemistry and mechanisms of action.

Authors:  M J Peach
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

2.  Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.

Authors:  T K Sawyer; D T Pals; B Mao; D J Staples; A E de Vaux; L L Maggiora; J A Affholter; W Kati; D Duchamp; J B Hester
Journal:  J Med Chem       Date:  1988-01       Impact factor: 7.446

3.  Renin.

Authors:  E E Slater
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  On the specificity of human renin. Studies with peptide inhibitors.

Authors:  K Poulsen; E Haber; J Burton
Journal:  Biochim Biophys Acta       Date:  1976-12-08

5.  An orally active inhibitor of renin.

Authors:  D T Pals; S Thaisrivongs; J A Lawson; W M Kati; S R Turner; G L DeGraaf; D W Harris; G A Johnson
Journal:  Hypertension       Date:  1986-12       Impact factor: 10.190

6.  Renin activity determination using human plasma as a substrate.

Authors:  J C Cornette; D B Evans; A M Furlong; S K Sharma
Journal:  Anal Biochem       Date:  1987-05-15       Impact factor: 3.365

7.  Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.

Authors:  J Boger; L S Payne; D S Perlow; N S Lohr; M Poe; E H Blaine; E H Ulm; T W Schorn; B I LaMont; T Y Lin
Journal:  J Med Chem       Date:  1985-12       Impact factor: 7.446

8.  alpha,alpha-Difluoro-beta-aminodeoxystatine-containing renin inhibitory peptides.

Authors:  S Thaisrivongs; H J Schostarez; D T Pals; S R Turner
Journal:  J Med Chem       Date:  1987-10       Impact factor: 7.446

9.  Human renin: a new class of inhibitors.

Authors:  J G Dann; D K Stammers; C J Harris; R J Arrowsmith; D E Davies; G W Hardy; J A Morton
Journal:  Biochem Biophys Res Commun       Date:  1986-01-14       Impact factor: 3.575

10.  Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.

Authors:  J Burton; R J Cody; J A Herd; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

View more
  1 in total

1.  Development of activity assays for high-volume evaluation of human immunodeficiency virus (HIV) protease inhibitors in rat serum: results with ditekiren.

Authors:  K F Wilkinson; B D Rush; S K Sharma; D B Evans; M J Ruwart; J M Friis; M J Bohanon; P K Tomich
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.